Legislation – The Health Protection (Coronavirus, International Travel and Operator Liability) (England) (Amendment) (No. 12) Regulations 2021
Amendment of Schedule 814.
(1)
(2)
In sub-paragraph (2) of paragraph 3 (consequences of test results), for “(2) and (6)” substitute “(2), (6) and (7A)”.
(3)
“(ha)
where—
(i)
a sample is to be sequenced in accordance with paragraph (h), and
(ii)
the sequencing is to take place at a laboratory (“the sequencing laboratory”) other than the laboratory at which the sample was initially processed (“the diagnostic laboratory”),
they secure that the sample is received at the sequencing laboratory no later than 24 hours after the result of the initial processing becomes known to the diagnostic laboratory;”.
(4)
In sub-paragraph (1) of paragraph 9 (day 8 tests: private provider requirements)—
(a)
“(ha)
where—
(i)
a sample is to be sequenced in accordance with paragraph (h), and
(ii)
the sequencing is to take place at a laboratory (“the sequencing laboratory”) other than the laboratory at which the sample was initially processed (“the diagnostic laboratory”);
they secure that the sample is received at the sequencing laboratory no later than 24 hours after the result of the initial processing becomes known to the diagnostic laboratory;”;
(b)
in paragraph (l), for “Public Health England” substitute “the United Kingdom Health Security Agency”.